FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
LC-MS/MS Quantitative Analysis of NDMA in Ranitidine Active Pharmaceutical Ingredient (API) and Drug Product using the SCIEX 4500 QTRAP
The LC-MS/MS method described in this technical note using Kinetex Biphenyl column is similar to the LC-MS/MS based analytical method recommended by USFDA as other methods, such as GC-MS, which use elevated temperatures have been reported to generate NDMA via reaction of ranitidine with itself, and this will result in an overestimation of NDMA present in ranitidine API and drug products.
LC-MS/MS Quantitative Analysis of NDMA in Ranitidine Active Pharmaceutical Ingredient (API) and Drug Product using the SCIEX 4500 QTRAP
The LC-MS/MS method described in this technical note using Kinetex Biphenyl column is similar to the LC-MS/MS based analytical method recommended by USFDA as other methods, such as GC-MS, which use elevated temperatures have been reported to generate NDMA via reaction of ranitidine with itself, and this will result in an overestimation of NDMA present in ranitidine API and drug products.